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YThe aim of this study was to determine whether there are differences between non-
ST- and ST-segment elevation myocardial infarction (STEMI) for octogenarians un-
derwent DES implantation.
METHODS Clinical data of 164 octogenarians with STEMI (n¼115) or non-STEMI
(n¼49) who received the treatment of DES were retrospectively analyzed. The pri-
mary endpoint was the rate of major adverse cardiac events (MACE).
RESULTS The octogenarians with STEMI or non-STEME had similarly low ejection
fraction (EF, 0.420.16 vs. 0.430.18, p¼719) and comparatively high percentage of
chronic renal insufﬁciency (23.4% vs. 25.7%, p¼0.764). The patients with STEMI had
higher in-hospital, but similar out-hospital occurrence of cardiac death compared to
those with non-STEMI. There were no differences in rates of MACE (26.5% vs. 24.6%,
p¼0.790), all cause death (22.4% vs. 19.3%, p¼0.646) and TLR (5.0% vs. 6.9%,
p¼1.000) between the two groups at 1 year follow-up.
CONCLUSIONS The occurrence of MACE, mainly driven by all cause death, was high
in octogenarians with AMI underwent DES. The octogenarians with STEMI had higher
risk of in-hospital cardiac death, but comparable clinical outcomes compared to those
with non-STEMI at 1 year follow-up.
Table I. In-hospital, 1-year clinical outcomesVariableNon-STEMI
(n[115)STEMI
(n[49) p- valueClinical success (%) 95.7 83.7 0.022in-hospital Death 2.6 16.3% 0.003in-hospital Cardiac death 2.6 14.3 0.0081 year follow-up (%)MACE 24.6 26.5 0.790Death 19.3 22.4 0.646Cardiac death 7.0 18.4 0.028Cardiac death out-hospital 4.5 4.9 1.000Q-wave MI 0 0 _TLR 6.9 5.0 1.000Stent thrombosis 0.9 0 1.000MACE: Major adverse cardiac events; MI: Myocardial infarction; TLR: Target lesion revascularization
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Clinical Outcomes Comparison Between First- And Second-generation
Drug-eluting Stents In Octogenarians With Acute Myocardial Infarction
Wenjie Tian, Rebecca Torguson, Ricardo Escarcega Alarcon,
Marco De Magalhaes Pereira, Thibault Lhermusier, Nevin Baker, Hideaki Ota,
Ron Waksman
MedStar Washington Hospital Center, Washington, DC
BACKGROUND Coronary intervention is infrequently performed in octogenarians and
the clinical outcomes of drug-eluting stents (DES) in octogenarians with acute
myocardial infarction (AMI) are limited. The aim of this study was to determine
whether there are differences between the ﬁrst- and second-generation DES for oc-
togenarians with AMI.
METHODS Clinical data of 164 octogenarians with AMI who underwent ﬁrst-genera-
tion DES (n¼104, 167 lesions) or second-generation DES (n¼60, 86 lesions) implan-
tation were retrospectively analyzed. The primary endpoint was the rate of major
adverse cardiac events (MACE) at 1 year follow-up.
RESULTS Baseline clinical and procedural characteristics were similar between the
two groups, except for less left main lesions (3.6% vs. 10.5%, p¼0.027) and greater
stent length (20.068.29mm vs. 16.164.85mm, p<0.001) in the ﬁrst-generation DES
group. The clinical success rate was similar in the two groups (89.4% vs. 96.7%,
p¼0.136). Compared with second-generation DES group, there were no differences in
the occurrence of MACE (27.2% vs. 21.7%, p¼0.434), TLR (5.7% vs. 7.4%, p¼1.000) and
all-cause death (23.3% vs. 15.0%, p¼0.203) in the second-generation DES group at 1-
year follow-up. The occurrence of stent thrombosis was similar (1% vs. 0%, p¼1.000)
in the two groups.
CONCLUSIONS The occurrence of MACE, mainly driven by all-cause death, was high
in octogenarians with AMI. The ﬁrst- and second-generation DES resulted in com-
parable outcomes at 1 year follow-up.Table I. 6-month and 1-year clinical outcomesVariable1-st generation DES
(n[104, 167 lesions)2-nd generation DES
(n[60, 86 lesions) p- value6 months follow-up (%)MACE 18.3 15.0 0.592All cause death 17.3 10.0 0.202Cardiac death 12.5 3.3 0.019Q-wave MI 1.1 3.6 0.556TLR 2.1 5.4 0.362Stent thrombosis 1.0 0 1.0001 year follow-up (%)MACE 27.2 21.7 0.434All cause death 23.3 15.0 0.203Cardiac death 12.5 6.6 0.171Q-wave MI 1.1 5.6 0.154TLR 5.7 7.4 1.000Stent thrombosis 1.0 0 1.000MACE: Major adverse cardiac events; MI: Myocardial infarction; TLR: Target lesion revascularizationCRT-110
Elevated Left Ventricular End-diastolic Pressure Predicts a Higher Rate of In-
hospital and 30-day Major Adverse Cardiac Events in Patients with Non-ST
Elevation Myocardial Infarction
Akihiro Kobayashi, Naoki Misumida, Yumiko Kanei, John Fox
Mount Sinai Beth Israel Medical Center, New York, NY
BACKGROUND Elevated left ventricular end-diastolic pressure (LVEDP) has been
shown to predict adverse outcomes in patients with ST elevation myocardial infarc-
tion. However, the prognostic value of elevated LVEDP in patients with non-ST
elevation myocardial infarction (NSTEMI) has not been fully elucidated.
METHODS We performed a retrospective analysis of 481 consecutive patients pre-
senting with NSTEMI who underwent coronary angiography within ﬁve days after
presentation from January 2013 to June 2014. LVEDP was measured during the index
cardiac catheterization. Patients without LVEDP data were excluded. Patients were
categorized into an elevated LVEDP group and control group. Baseline and angio-
graphic characteristics, in-hospital revascularization procedures as well as in-hospital
and 30-day major adverse cardiac event (MACE) including death, recurrent myocardial
infarction, and target vessel revascularizationwere compared between the two groups.
RESULTS LVEDP was measured in 367 patients. The median LVEDP was 19.0 mm Hg
(interquartile; 14.0, 24.0 mmHg). By receiver operating characteristic curve analysis,
the optimal cutoff value in predicting in-hospital MACE was 22 mmHg (area under the
curve was 0.80). As a result, 109 patients (29.7%) were categorized into the elevated
LVEDP group. Patients with elevated LVEDP were more likely to have hypertension
(79.8% vs. 69.0%, p¼0.03) and diabetes mellitus (50.5% vs. 32.9%, p¼0.002). There
was no signiﬁcant difference in the rates of multivessel disease, impaired coronary
blood ﬂow, in-hospital percutaneous coronary intervention and coronary artery
bypass grafting. Patients with elevated LVEDP had a higher rate of in-hospital heart
failure (22.0% vs. 13.2%, p¼0.03), in-hospital MACE (4.6% vs. 0.4%, p¼0.01) as well as
30-day MACE (8.3% vs. 2.7%, p¼0.02) compared with the control group. There was no
signiﬁcant difference in the rates of in-hospital heart failure, and in-hospital and 30-
day MACE between those with and without LVEDP measurements.
CONCLUSION Elevated LVEDP was signiﬁcantly associated with a higher rate of in-
hospital heart failure, in-hospital MACE and 30-day MACE in patients with NSTEMI.
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Prevalence and Prognostic Value of Wellens’ Sign in Patients with Non-ST
Elevation Myocardial Infarction
Akihiro Kobayashi, Naoki Misumida, Yumiko Kanei, John fox
Mount Sinai Beth Israel Medical Center, New York, NY
BACKGROUND Deeply inverted or biphasic T-waves in anterior leads, so-called
Wellens’ sign, has been considered to represent impending ischemia in left anterior
descending (LAD) territory. However, this electrocardiographic pattern may be
observed in patients without a critical stenosis in LAD artery. We aimed to evaluate its
prevalence, clinical signiﬁcance and prognostic value of Wellens’ sign in patients with
non-ST elevation myocardial infarction (NSTEMI).
METHODS We performed a retrospective analysis of 481 consecutive patients pre-
senting with NSTEMI who underwent coronary angiography within ﬁve days after
presentation. Patients with complete bundle branch block and ventricular paced
rhythm were excluded. Electrocardiograms were interpreted in a blinded fashion.
Wellens’ sign was deﬁned as either there are deeply inverted T-waves (3.0mV) or
biphasic T-waves in both lead V2 and V3. Patients were categorized into a Wellens
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Ygroup and control group. Baseline and angiographic characteristics, in-hospital
revascularization procedures, in-hospital and 30-day major adverse cardiac event
(MACE) including death, recurrent myocardial infarction, and target vessel revascu-
larization were compared between the two groups.
RESULTS Among 424 patients included in the ﬁnal analysis, 18 patients (4.2%) had
Wellens’ sign. Among the 18 patients, 9 had a LAD culprit lesion (3 proximal, 5mid, and 1
distal LAD), 2 had a non-LAD culprit lesion, and 4 patients had nonobstructive coronary
artery disease. There was no signiﬁcant difference in the rate of previous myocardial
infarction or percutaneous coronary intervention between the patients with and
without Wellens’ sign. Patients with Wellens’ sign had a higher prevalence of LAD
culprit lesion (50% vs. 22.9%, p¼0.008). Peak troponin I values were comparable be-
tween the two groups (median [interquartile]; 0.92 [0.13-3.7] ng/mL vs. 0.66 [0.10-5.39]
ng/mL, p¼0.80). There was no signiﬁcant difference in the rate of Thrombolysis In
Myocardial Infarction grade 0-1 ﬂow (16.7% vs. 24.6%, p¼0.44), and in-hospital revas-
cularization (55.5% vs. 62.3%, p¼0.56). At the 30-day follow-up, no signiﬁcant differ-
ence was found in the rate of MACE between the two groups (0% vs. 4.2%, p¼0.38).
CONCLUSION Our study demonstrated that 1) Wellens’ sign was observed in 4.2 % in
this cohort; 2) Wellens’ sign had a predictive value for LAD culprit lesion, but it was
also observed in patients with non-LAD culprit lesions; and 3) Wellens’ sign did not
have a short-term prognostic value among patients with NSTEMI.
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Angiographic Thrombus Predicts Larger Infarct Size in Patients with Non-ST
Elevation Myocardial Infarction
Naoki Misumida, Akihiro Kobayashi, John Fox, Yumiko Kanei
Mount Sinai Beth Israel, New York, NY
BACKGROUND Angiographic thrombus is associated with larger infarct size in ST
elevation myocardial infarction (STEMI) population and thrombus aspiration has
been shown to improve coronary perfusion in STEMI. In contrast, a recent random-
ized trial in non-ST elevation myocardial infarction (NSTEMI) population showed
thrombus aspiration did not lead to a reduction in microvascular obstruction. We
aimed to assess the impact of thrombus on infarct size in NSTEMI population.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Patients with nonobstructive coronary artery deﬁned as less than 70% stenosis (50%
in the left main coronary artery) were excluded. Infarct size was determined as peak
cardiac troponin I value. Angiographic thrombus was graded according to Throm-
bolysis In Myocardial Infarction (TIMI) grade. High-grade and low-grade thrombi
were deﬁned as TIMI grade 4-5 and TIMI grade 1-3, respectively. Patent infarct-related
artery was deﬁned as TIMI grade 2-3 ﬂow. Clinical and angiographic characteristics,
infarct size and in-hospital major adverse cardiac event (MACE) including death,
recurrent myocardial infarction, and target vessel revascularization were compared
between patients with and without angiographic thrombus.
RESULTS After excluding 103 patients with nonobstructive coronary artery disease,
378 patients were included in the ﬁnal analysis. Among 378 patients, 162 (42.9%)
patients had angiographic thrombus, of which 71 patients had high-grade thrombus.
Peak troponin values were signiﬁcantly higher in patients with thrombus compared
with those without thrombus (median [interquartile]; 3.66 [0.36-13.3] ng/ml vs. 0.69
[0.10-4.36] ng/ml, p<0.001). After excluding patients with TIMI grade 0/1 ﬂow, pa-
tients with thrombus had a higher peak troponin (1.53 [0.27-6.83] ng/ml vs. 0.49
[0.10-2.95] ng/ml, p¼0.003). Patients with thrombus had a higher rate of in-hospital
revascularization (89.5% vs. 68.5%, p<0.001). In the subgroup of the patients who
underwent ad-hoc percutaneous coronary intervention (n¼217), patients with
thrombus had a higher rate of post-procedural TIMI 0 ﬂow (5.5% vs. 0%, p¼0.03).
There was no signiﬁcant difference in the rate of in-hospital MACE.
CONCLUSION Our study demonstrated that angiographic thrombus was associated
with larger infarct size indicated by higher peak troponin values in patients with
NSTEMI, even among patients with patent infarct-related artery.
CRT-113
Prevalence and Outcomes of Non-ST Elevation Myocardial Infarction Resulting
from Stent Thrombosis
Naoki Misumida, Akihiro Kobayahsi, John Fox, Yumiko Kanei
Mount Sinai Beth Israel, New York, NY
BACKGROUND Stent thrombosis is one of the most devastating adverse events
following percutaneous coronary intervention. Stent thrombosis has been reported to
account for about 7% cases of ST elevation myocardial infarction in contemporary
practice and was associated with worse outcomes. In contrast, there are limited data
about non-ST elevation myocardial infarction (NSTEMI) resulting from stent throm-
bosis. Therefore, we aimed to evaluate the prevalence and outcomes of NSTEMI due
to stent thrombosis.
METHODS We performed a retrospective analysis of 481 consecutive patients with
NSTEMI who underwent coronary angiography within ﬁve days after presentation.
Stent thrombosis was deﬁned according to the Academic Research Consortiumcriteria. Infarct size was measured as the peak cardiac troponin I (cTnI) value and a
large myocardial infarction (MI) was deﬁned as a peak cTnI greater than 90th
percentile of the study population. Clinical and angiographic characteristics, the
incidence of a large MI and in-hospital and 30-day major adverse cardiac event
(MACE) including death, recurrent myocardial infarction, and target vessel revascu-
larization were compared between patients with and without stent thrombosis.
RESULTS Among 481 patients, 18 (3.7%) patients had angiographically conﬁrmed
stent thrombosis. There was no signiﬁcant difference in baseline characteristics. At
the time of the events, ten patients with stent thrombosis were taking dual anti-
platelet therapy. There was a trend toward higher peak troponin values in patients
with stent thrombosis (median [interquartile range]; 3.41 [0.15-47.6] ng/ml vs. 0.68
[0.10-5.17] ng/ml, p¼0.13). Patients with stent thrombosis had a higher incidence of
large MI (27.8% vs. 9.3%, p¼0.03). There was no signiﬁcant difference in the rate of
multivessel disease, left anterior descending artery culprit lesion and in-hospital
revascularization. Among patients who underwent ad-hoc percutaneous coronary
intervention, patients with stent thrombus had a higher rate of post-procedural TIMI
grade 0 ﬂow (20.0% vs. 1.9%, p¼0.03). Patients with stent thrombosis had a higher
incidence of in-hospital MACE (11.1% vs. 1.3%, p¼0.03) and 30-day MACE (16.7% vs.
4.1%, p¼0.04).
CONCLUSION Stent thrombosis accounted for 3.7% cases of NSTEMI in this cohort of
patients. Our study showed that patients with NSTEMI resulting from stent throm-
bosis had a higher rate of large MI, in-hospital and 30-day MACE.
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Echocardiographic Left Ventricular Hypertrophy Predicts In-hospital Heart
Failure in Patients with Non-ST Elevation Myocardial Infarction
Naoki Misumida, Akihiro Kobayashi, John Fox, Yumiko Kanei
Mount Sinai Beth Israel, New York, NY
BACKGROUND Left ventricular hypertrophy (LVH) is a well-known predictor of heart
failure in the general population. However, its clinical signiﬁcance in the setting of
acute coronary syndrome has not been well established. We aimed to determine the
predictive value of echocardiographic LVH for in-hospital heart failure in patients
with non-ST elevation myocardial infarction (NSTEMI).
METHODS We performed a retrospective analysis of 481 consecutive NSTEMI patients
who underwent coronary angiography within ﬁve days after presentation. Trans-
thoracic echocardiography was performed in a standard fashion during hospitalization
and 309 patients had sufﬁcient data to calculate left ventricular mass index. Obstruc-
tive coronary artery diseasewas deﬁned as stenosis greater than or equal to 70% (50% in
the left main coronary artery). LVHwas deﬁned as left ventricular mass index>95 g/m2
(female) and > 115 g/m2 (male). Baseline and angiographic characteristics, in-hospital
revascularization procedures and heart failure as well as in-hospital and 30-day major
adverse cardiac event (MACE) including death, recurrent myocardial infarction, and
target vessel revascularization were compared between the two groups.
RESULTS Among 309 patients, 91 patients (29.4%) had echocardiographic LVH, 241
patients (78.0%) had obstructive coronary artery disease and 182 patients (58.9%)
underwent in-hospital revascularization. The LVH group had a higher rate of chronic
kidney disease (48.4% vs. 27.1%, p¼0.001). Patients with echocardiographic LVH had
a higher incidence of in-hospital heart failure (33.0% vs. 11.9%, p<0.001). The asso-
ciation between LVH and in-hospital heart failure remained signiﬁcant in the sub-
groups of patients who had obstructive coronary artery disease (31.9% vs. 14.8%,
p¼0.002) and those who underwent in-hospital revascularization (31.1% vs. 14.6%,
p¼0.01). The association between echocardiographic LVH and in-hospital heart fail-
ure persisted after adjusting for age, hypertension, chronic kidney disease and left
ventricular ejection fraction less than 50% (odds ratio 2.35; 95% conﬁdence interval,
1.21-4.56; p¼0.01). At 30-day follow-up, there was a trend toward a higher incidence
of MACE in patients with LVH (6.6% vs. 2.8%, p¼0.11).
CONCLUSION Our study demonstrated that echocardiographic LVH was observed in
a quarter of NSTEMI patients and an independent predictor for in-hospital heart
failure.
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Qt Dispersion Correlation to St Segment Resolution In STEMI Patients
Ouafa Hamza, Abdelmalek Azzouz, Omar Ait Mokhtar, Nabil Bendaoud,
Kheireddine Merad, Salim Benkhedda
CHU mustapha Pacha, Agiers, Algeria
BACKGROUND QT dispersion (Qtd) is deﬁned as the difference between the maximal
and the minimal values of the QT through the peripheral and precordial leads. It is
considered as an arrhythmogenic indice and reﬂects the inhomogeneity of
repolarization.
AIM To investigate the effect of revascularization on corrected QT interval (QTc) and
Qtd in acute STEMI patients.
METHODS We conducted a prospective study in which patients presenting with acute
STEMI who underwent primary percutaneous coronary intervention (PCI) with suc-
cessful recanalization were enrolled. QTc and QTd were calculated before, 90 minutes
